4.7 Article

Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

The anti-hepatocellular carcinoma effect of Brucea javanica oil in ascitic tumor-bearing mice: The detection of brusatol and its role

Tongtong Wang et al.

Summary: The study found that BJO and BE-BJO significantly prolonged the survival time of H22 ascites tumor-bearing mice, while BF-BJO showed no obvious effect. Additionally, BJO and BE-BJO exhibited pronounced anti-HCC activity by suppressing the growth of implanted hepatoma H22 in mice, including weight, abdominal circumference, ascites volume, and cancer cell viability, with a relatively wide safety margin.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Oncology

Acute myeloid leukemia: current progress and future directions

Hagop Kantarjian et al.

Summary: Advancements in understanding and therapy of AML have been rapid, with targeted therapies such as venetoclax and FLT3 inhibitors being approved for various indications. Expertise is crucial in managing the complexity of AML treatment, tailored to the specific subentities for optimal outcomes.

BLOOD CANCER JOURNAL (2021)

Article Oncology

A Novel Nrf2 Pathway Inhibitor Sensitizes Keap1-Mutant Lung Cancer Cells to Chemotherapy

Di Zhang et al.

Summary: The Nrf2-Keap1-ARE pathway is a key regulator of oxidative stress and a potential target for cancer therapy, particularly in lung cancer. MSU38225, a newly identified small molecule, suppresses Nrf2 pathway activity by reducing transcriptional activity and downstream protein expression, inhibiting cancer cell growth and increasing sensitivity to chemotherapies.

MOLECULAR CANCER THERAPEUTICS (2021)

Article Biochemistry & Molecular Biology

Metabolic Responses to Reductive Stress

Wusheng Xiao et al.

ANTIOXIDANTS & REDOX SIGNALING (2020)

Review Biochemistry & Molecular Biology

Current Landscape of NRF2 Biomarkers in Clinical Trials

Yoko Yagishita et al.

ANTIOXIDANTS (2020)

Review Oncology

FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies

Vanessa E. Kennedy et al.

FRONTIERS IN ONCOLOGY (2020)

Article Oncology

Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia

Sankaranarayanan Kannan et al.

MOLECULAR CANCER THERAPEUTICS (2019)

Review Hematology

Maintenance therapy in AML: The past, the present and the future

Matteo Molica et al.

AMERICAN JOURNAL OF HEMATOLOGY (2019)

Review Biochemistry & Molecular Biology

The Role of Reactive Oxygen Species in Acute Myeloid Leukaemia

Jonathan R. Sillar et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Pharmacology & Pharmacy

Targeting oncogenic transcription factors by polyphenols: A novel approach for cancer therapy

Chitra Rajagopal et al.

PHARMACOLOGICAL RESEARCH (2018)

Article

Heme oxygenase inhibition in cancers: possible tools and targets

Paulina Podkalicka et al.

Wspolczesna Onkologia-Contemporary Oncology (2018)

Review Hematology

NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML

Ashok Kumar Jayavelu et al.

EXPERIMENTAL HEMATOLOGY (2016)

Article Cell Biology

The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance

A. L. Furfaro et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Review Pharmacology & Pharmacy

HO-1/CO system in tumor growth, angiogenesis and metabolism Targeting HO-1 as an anti-tumor therapy

Agnieszka Loboda et al.

VASCULAR PHARMACOLOGY (2015)

Review Biochemistry & Molecular Biology

Redox Control of Leukemia: From Molecular Mechanisms to Therapeutic Opportunities

Mary E. Irwin et al.

ANTIOXIDANTS & REDOX SIGNALING (2013)

Article Cardiac & Cardiovascular Systems

Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy

Sankaranarayanan Kannan et al.

CARDIOVASCULAR RESEARCH (2013)

Article Immunology

Notch activation inhibits AML growth and survival: a potential therapeutic approach

Sankaranarayanan Kannan et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2013)

Review Cell Biology

Role of Glutathione in Cancer Progression and Chemoresistance

Nicola Traverso et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)

Article Multidisciplinary Sciences

Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism

Dongmei Ren et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Review Pharmacology & Pharmacy

Targeting Heme Oxygenase-1 in Vascular Disease

William Durante

CURRENT DRUG TARGETS (2010)

Article Multidisciplinary Sciences

Nrf2 mediates cancer protection but not prolongevity induced by caloric restriction

Kevin J. Pearson et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Medicine, Research & Experimental

Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis

RK Thimmulappa et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Biochemistry & Molecular Biology

Nrf3 negatively regulates antioxidant-response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene

K Sankaranarayanan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line

JS Armstrong et al.

CELL DEATH AND DIFFERENTIATION (2002)